Insomnia

A major global study presented at the American Heart Association's 2025 Scientific Sessions links long-term melatonin use to a 90% higher risk of heart failure and nearly double the death rate

Use of sleep medication and inability to fall asleep quickly are associated with an increased risk of developing dementia over a 10 year period, according to a study. The research, published in the American Journal of Preventive Medicine, found a significant link between three measures of sleep disturbance and the risk for developing dementia, a neurodegenerative disease. The researchers associate sleep-initiation insomnia (trouble falling asleep within 30 minutes) and sleep medication use with higher risk for developing dementia. They also found that people who reported having sleep-maintenance insomnia (trouble falling back to sleep after waking) were less likely to develop dementia over the course of the study. "We expected sleep-initiation insomnia and sleep medication usage to increase dementia risk, but we were surprised to find sleep-maintenance insomnia decreased dementia risk," explained lead investigator Roger Wong, an Assistant Professor at SUNY Upstate Medical Universit

The drug, to be available under the brand name Quviviq, was approved in doses of 25 mg and 50 mg based on data from two late-stage trials

Consumer spends & factory output boost China recovery, Japan vaults back from recession, full lockdown imposed in Austria and other pandemic-related news across the globe

For the current study, researchers examined data on 405 cancer patients in Germany

Patients reported more improvement in their insomnia symptoms after 4, 8 and 24 weeks

Strict sleep schedule and avoiding bright light in the night are also effective

To investigate whether web-based CBT-I is effective over the long term